Author:
Zhang Zhongheng,Hongying Ni
Publisher
Springer Science and Business Media LLC
Subject
Critical Care and Intensive Care Medicine
Reference26 articles.
1. Uchino S, Fealy N, Baldwin I, Morimatsu H, Bellomo R (2003) Continuous is not continuous: the incidence and impact of circuit “down-time” on uraemic control during continuous veno-venous haemofiltration. Intensive Care Med 29:575–578
2. Uchino S, Bellomo R, Morimatsu H, Morgera S, Schetz M, Tan I, Bouman C, Macedo E, Gibney N, Tolwani A, Oudemans-van Straaten H, Ronco C, Kellum JA (2007) Continuous renal replacement therapy: a worldwide practice survey. The beginning and ending supportive therapy for the kidney (B.E.S.T. kidney) investigators. Intensive Care Med 33:1563–1570
3. Tsang DJ, Tuckfield A, Macisaac CM (2011) Audit of safety and quality of the use of enoxaparin for anticoagulation in continuous renal replacement therapy. Crit Care Resusc 13:24–27
4. Gajra A, Vajpayee N, Smith A, Poiesz BJ, Narsipur S (2007) Lepirudin for anticoagulation in patients with heparin-induced thrombocytopenia treated with continuous renal replacement therapy. Am J Hematol 82:391–393
5. Link A, Girndt M, Selejan S, Mathes A, Böhm M, Rensing H (2009) Argatroban for anticoagulation in continuous renal replacement therapy. Crit Care Med 37:105–110
Cited by
133 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献